Pyridoxamine protects human granulosa cells against advanced glycation end-products-induced steroidogenesis disturbances

Mol Biol Rep. 2023 Oct;50(10):8537-8549. doi: 10.1007/s11033-023-08723-8. Epub 2023 Aug 29.

Abstract

Background: Ovarian advanced glycation end-products (AGEs) accumulation is associated with ovarian granulosa cells (GCs) dysfunction. Vitamin B6 derivatives positively affected reproduction. The current study was conducted to elucidate the AGEs effects on human luteinized mural GCs steroidogenesis in the presence or absence of pyridoxamine (PM).

Methods and results: Isolated GCs of 50 healthy women were divided into four parts and treated with media alone (Control), PM alone, or human glycated albumin (HGA) with/without PM. Main steroidogenic enzymes and hormones were assessed by qRT-PCR and ELISA. The AGE receptor (RAGE) protein was also determined using Western blotting. The non-toxic concentration of HGA increased the expression of RAGE, StAR, 3β-HSD, and 17β-HSD (P < 0.0001 for all) but decreased the expression of CYP19A1 at mRNA levels. The increased RAGE protein expression was also confirmed by western blot analysis. These effects resulted in declined estradiol (E2), slightly, and a sharp rise in progesterone (P4) and testosterone (T) levels, respectively. PM, on its own, ameliorated the HGA-altered enzyme expression and, thereby, corrected the aberrant levels of E2, P4, and T. These effects are likely mediated by regulating the RAGE gene and protein expression.

Conclusion: This study indicates that hormonal dysfunctions induced by the AGEs-RAGE axis in luteinized GCs are likely rectified by PM treatment. This effect is likely acquired by reduced expression of RAGE. A better understanding of how AGEs and PM interact in ovarian physiology and pathology may lead to more targeted therapy for treating ovarian dysfunction.

Keywords: Advanced glycation end-products; Granulosa cells; Pyridoxamine; Sex steroid hormone; Steroidogenic enzymes.

MeSH terms

  • Female
  • Glycation End Products, Advanced
  • Granulosa Cells
  • Humans
  • Maillard Reaction*
  • Pyridoxamine* / pharmacology
  • Vitamin B 6

Substances

  • Pyridoxamine
  • Vitamin B 6
  • Glycation End Products, Advanced